Supplemental material
Scandinavian Journal of Gastroenterology
Volume 56, 2021 - Issue 10
Original Article
First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study
Karoline Anisdahla Department of Gastroenterology, Oslo University Hospital, Oslo, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, NorwayCorrespondence[email protected]
https://orcid.org/0000-0003-2041-9100View further author information
https://orcid.org/0000-0003-2041-9100View further author information, Sandre Svatun Lirhusc Department of Health Management and Health Economics, University of Oslo, Oslo, Norwayhttps://orcid.org/0000-0002-0895-7654View further author information
https://orcid.org/0000-0002-0895-7654View further author information, Asle W. Medhusa Department of Gastroenterology, Oslo University Hospital, Oslo, Norwayhttps://orcid.org/0000-0001-7118-5127View further author information
https://orcid.org/0000-0001-7118-5127View further author information, Bjørn Mouma Department of Gastroenterology, Oslo University Hospital, Oslo, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, Norwayhttps://orcid.org/0000-0002-5884-4543View further author information
https://orcid.org/0000-0002-5884-4543View further author information, & Marte Lie Høivika Department of Gastroenterology, Oslo University Hospital, Oslo, Norway;b Institute of Clinical Medicine, University of Oslo, Oslo, Norwayhttps://orcid.org/0000-0002-0104-465XView further author information
https://orcid.org/0000-0002-0104-465XView further author information